Results 71 to 80 of about 10,303 (224)
Detection of Antibody and Antigen for Lassa Virus Nucleoprotein in Monkeys from Southern Nigeria
Journal of Epidemiology and Global Health, 2019 Lassa fever is a deadly viral haemorrhagic fever caused by Lassa Virus (LASV). Rodents, especially, Mystomys natalensis, are the known reservoirs of LASV and humans are the defined hosts.
Bamidele Nyemike Ogunro +6 more
doaj +1 more source
Fractional Order Epidemic System of Saturated Rate of Incidence: A Neural Network Approach
Engineering Reports, Volume 8, Issue 3, March 2026.The workflow depictions of the mathematical fractional order saturated rate of incidence model using the process of Levenberg–Marquardt Backpropagation neural network. The designed neural network contains 20 numbers of neurons, a sigmoid activation function, and a single hidden layer structure.
Zulqurnain Sabir +3 more
wiley +1 more source
Comparative studies on Mopeia viruses and other Arenaviridae, particularly Lassa virus
, 1983 This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University.Serologically related arenaviruses have been isolated from West Africa, Mozambique, Zimbabwe and the Central African Republic.
Lloyd, Graham
core
Prevalence of Lassa virus among rodents trapped in three South-South States of Nigeria
Journal of Vector Borne Diseases, 2017 Background & objectives: Lassa fever has been endemic in Nigeria since 1969. The rodent Mastomys natalensis has been widely claimed to be the reservoir host of the Lassa virus.
D E Agbonlahor +12 more
doaj
BMC Infectious Diseases, 2004 Background The potential use of microorganisms as agents of biological warfare (BW) is a growing concern. Lassa virus, a member of the Arenavirus class of Hemorrhagic fever (HF) viruses has emerged as a worldwide concern among public health officials ...
Tibbles Heather E +4 more
doaj +1 more source
Health Science Reports, Volume 9, Issue 3, March 2026.ABSTRACT Background and Aims Africa has significant challenges in meeting its vaccination needs, including inadequate manufacturing capacity, infrastructure deficiencies, a scarcity of experienced personnel, regulatory hurdles, restricted access to technology and intellectual property.
Courage Chandipwisa +3 more
wiley +1 more source
, 2013 Lassa fever virus is one of the most dangerous viruses of arenaviridae family, causing more than 500,000 infections per year in Africa. The fatality rate for hospitalized patients is as high as 20%.
Qi, Xiaoxuan
core
Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design
Immunological Reviews, Volume 338, Issue 1, March 2026.ABSTRACT Vaccination represents one of the most impactful public health achievements, preventing 3.5 to 5 million deaths annually according to estimates of the World Health Organization. Yet, recent outbreaks of emerging and reemerging infectious diseases highlight the need for rapid and strategic vaccine development using vaccine platforms ...
Ilka Grewe +2 more
wiley +1 more source
A novel single‐cell NAD‐ME C4 subtype integrated with CAM and bicarbonate use in an aquatic plant
New Phytologist, Volume 249, Issue 5, Page 2386-2401, March 2026.Summary Many plants maximize photosynthesis by using a CO2‐concentrating mechanism (CCM). Based on physiology, the freshwater plant Ottelia alismoides has three CCMs: C4 metabolism (NAD‐malic enzyme (NAD‐ME) subtype) and bicarbonate‐use during the day plus crassulacean acid metabolism (CAM) at night and lacks Kranz anatomy. Here, we combined a range of
Hong Sheng Jiang +11 more
wiley +1 more source
Current research for a vaccine against Lassa hemorrhagic fever virus
, 2018 Bryce M Warner,1 David Safronetz,2 Derek R Stein2 1Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada; 2Zoonotic Diseases and Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada ...
Safronetz D, Warner BM, Stein DR
core